These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22378142)

  • 1. Elevated proportion of small, dense low-density lipoprotein particles and lower adiponectin blood levels predict early structural valve degeneration of bioprostheses.
    Shetty R; Girerd N; Côté N; Arsenault B; Després JP; Pibarot P; Mathieu P
    Cardiology; 2012; 121(1):20-6. PubMed ID: 22378142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between plasma lipoprotein levels and bioprosthetic valve structural degeneration.
    Nsaibia MJ; Mahmut A; Mahjoub H; Dahou A; Bouchareb R; Boulanger MC; Després JP; Bossé Y; Arsenault BJ; Larose E; Pibarot P; Mathieu P
    Heart; 2016 Dec; 102(23):1915-1921. PubMed ID: 27378363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lp-PLA2 is associated with structural valve degeneration of bioprostheses.
    Mahmut A; Mahjoub H; Boulanger MC; Fournier D; Després JP; Pibarot P; Mathieu P
    Eur J Clin Invest; 2014 Feb; 44(2):136-45. PubMed ID: 24328921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoB/ApoA-I ratio is associated with increased risk of bioprosthetic valve degeneration.
    Mahjoub H; Mathieu P; Sénéchal M; Larose E; Dumesnil J; Després JP; Pibarot P
    J Am Coll Cardiol; 2013 Feb; 61(7):752-61. PubMed ID: 23410546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-mediated inflammation and degeneration of bioprosthetic heart valves.
    Shetty R; Pibarot P; Audet A; Janvier R; Dagenais F; Perron J; Couture C; Voisine P; Després JP; Mathieu P
    Eur J Clin Invest; 2009 Jun; 39(6):471-80. PubMed ID: 19490057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis.
    Mohty D; Pibarot P; Després JP; Côté C; Arsenault B; Cartier A; Cosnay P; Couture C; Mathieu P
    Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):187-93. PubMed ID: 17975118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis.
    Côté C; Pibarot P; Després JP; Mohty D; Cartier A; Arsenault BJ; Couture C; Mathieu P
    Heart; 2008 Sep; 94(9):1175-80. PubMed ID: 17932090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimineralization treatment and patient-prosthesis mismatch are major determinants of the onset and incidence of structural valve degeneration in bioprosthetic heart valves.
    Flameng W; Rega F; Vercalsteren M; Herijgers P; Meuris B
    J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1219-24. PubMed ID: 23623617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results with the Biocor-SJM stentless porcine aortic bioprosthesis.
    Vrandecic M; Fantini FA; Filho BG; de O; da C; Vrandecic E
    J Heart Valve Dis; 2002 Jan; 11(1):47-53. PubMed ID: 11843505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves.
    Flameng W; Herregods MC; Vercalsteren M; Herijgers P; Bogaerts K; Meuris B
    Circulation; 2010 May; 121(19):2123-9. PubMed ID: 20439787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of transcatheter heart valves for a valve-in-valve implantation in patients with degenerated aortic bioprosthesis: technical considerations and results.
    Bapat V; Attia R; Redwood S; Hancock J; Wilson K; Young C; Thomas M
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1372-9; discussion 1379-80. PubMed ID: 23140962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative cholesterol levels do not predict explant for structural valve deterioration in patients undergoing bioprosthetic aortic valve replacement.
    Gring CN; Houghtaling P; Novaro GM; Roselli E; Smedira N; Banbury M; Blackstone E; Griffin BP
    J Heart Valve Dis; 2006 Mar; 15(2):261-8. PubMed ID: 16607910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologic findings in explanted Hancock II porcine bioprostheses.
    Butany J; Yu W; Silver MD; David TE
    J Heart Valve Dis; 1999 Jan; 8(1):4-15. PubMed ID: 10096476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: Technical considerations and results.
    Bapat V; Davies W; Attia R; Hancock J; Bolter K; Young C; Redwood S; Thomas M
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):917-22; discussion 922-4. PubMed ID: 25037622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome is associated with faster degeneration of bioprosthetic valves.
    Briand M; Pibarot P; Després JP; Voisine P; Dumesnil JG; Dagenais F; Mathieu P
    Circulation; 2006 Jul; 114(1 Suppl):I512-7. PubMed ID: 16820629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, prospective assessment of bioprosthetic valve durability. Hancock versus Carpentier-Edwards valves.
    Sarris GE; Robbins RC; Miller DC; Mitchell RS; Moore KA; Stinson EB; Oyer PE; Reitz BA; Shumway NE
    Circulation; 1993 Nov; 88(5 Pt 2):II55-64. PubMed ID: 8222197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements.
    Khawaja MZ; Haworth P; Ghuran A; Lee L; de Belder A; Hutchinson N; Trivedi U; Laborde JC; Hildick-Smith D
    J Am Coll Cardiol; 2010 Jan; 55(2):97-101. PubMed ID: 20117377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The imbalance between proliferation and apoptosis contributes to degeneration of aortic valves and bioprostheses.
    Tuleta I; Al Ghaddioui AK; Bauriedel G; Wernert N; Preusse CJ; Welz A; Nickenig G; Skowasch D
    Cardiol J; 2013; 20(3):268-76. PubMed ID: 23788301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late incidence and determinants of reoperation in patients with prosthetic heart valves.
    Ruel M; Kulik A; Rubens FD; Bédard P; Masters RG; Pipe AL; Mesana TG
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):364-70. PubMed ID: 15019662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic valve replacement with bioprostheses in liver transplant recipients.
    Segura I; Herrero JI; Martín A; Saénz de Buruaga JD; Quiroga J; Latorre G; Fernandez E; López-Coronado JL; Sangro B
    J Heart Valve Dis; 2000 May; 9(3):370-3. PubMed ID: 10888093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.